Skip to main content
Premium Trial:

Request an Annual Quote

HandyLab Gets $2M ATP Grant for DNA Analysis Device

NEW YORK, July 15 -Diagnostics startup HandyLab said today it has been awarded a $2 million ATP grant from the US National Institute of Standards and Technology to develop its portable DNA analysis device

 

The system under development uses microfluidics and electrochemical detection technologies, and is designed to process raw clinical and environmental samples. The system is being developed to perform PCR, RT-PCR, nucleic acid testing and bioassays for biodefense and for clinical diagnostics in hospital settings.

 

The Ann Arbor, Mich.-based company is attempting to develop this system as a low-cost and portable alternative to current options in field and point-of-care DNA, protein, and other clinical testing.

 

For a more in-depth view of HandyLab, see the October 2002 Genome Technology story.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.